Olga Sroka-Gumkowska

Katowice, SL 40055, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Small-Molecule Strategies for Polymyalgia Rheumatica and Giant Cell Arteritis in Older Adults.

Small-Molecule Strategies for Polymyalgia Rheumatica and Giant Cell Arteritis in Older Adults.

Journal: Molecules (Basel, Switzerland)

Published: April 30, 2026

Immunogenetics of Idiopathic Inflammatory Myopathies: The Role of HLA Genes Within and Beyond the Ancestral Haplotype.

Immunogenetics of Idiopathic Inflammatory Myopathies: The Role of HLA Genes Within and Beyond the Ancestral Haplotype.

Journal: Genes

Published: March 29, 2026

The Potential of Cardiac Biomarkers in Differentiating Disease Subtypes in Patients with Systemic Sclerosis: Focus on GDF15, MR-pro ANP, and suPAR.

The Potential of Cardiac Biomarkers in Differentiating Disease Subtypes in Patients with Systemic Sclerosis: Focus on GDF15, MR-pro ANP, and suPAR.

Journal: International journal of molecular sciences

Published: March 05, 2025

Assessment of myocardial structure and function in rheumatoid arthritis patients treated with biologics: tumor necrosis factor inhibitors and anti-interleukin-6 versus conventional disease-modifying drugs.

Assessment of myocardial structure and function in rheumatoid arthritis patients treated with biologics: tumor necrosis factor inhibitors and anti-interleukin-6 versus conventional disease-modifying drugs.

Journal: Reumatologia

Published: January 03, 2025

Immunogenetics of Systemic Sclerosis.

Immunogenetics of Systemic Sclerosis.

Journal: Genes

Published: April 07, 2024

Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis.

Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 29, 2023

Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus.

Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 01, 2022

Differential Impact of Biologic Therapy on Heart Function Biomarkers in Rheumatoid Arthritis Patients: Observational Study on Etanercept, Adalimumab, and Tocilizumab.

Differential Impact of Biologic Therapy on Heart Function Biomarkers in Rheumatoid Arthritis Patients: Observational Study on Etanercept, Adalimumab, and Tocilizumab.

Journal: Current pharmaceutical design

Published: January 21, 2022

Adhesion molecules: a way to understand lupus.

Adhesion molecules: a way to understand lupus.

Journal: Reumatologia

Published: December 30, 2021

Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment.

Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment.

Journal: Journal of clinical medicine

Published: April 26, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026